Sucampo Pharmaceuticals, Inc.·4

Jan 2, 4:56 PM ET

Driggs Alex 4

4 · Sucampo Pharmaceuticals, Inc. · Filed Jan 2, 2018

Insider Transaction Report

Form 4
Period: 2017-12-28
Driggs Alex
General Counsel & Corp. Sec.
Transactions
  • Tax Payment

    Common Stock, Class A

    2017-12-28$17.98/sh2,025$36,4105,424 total
Footnotes (2)
  • [F1]The transaction reported represents the non-discretionary withholding of shares to satisfy the reporting person's tax withholding obligations in connection with the non-reportable vesting and settlement of restricted stock units.
  • [F2]Common stock originally granted consists of restricted stocked units; this award was originally scheduled to vest on March 2, 2020, but was accelerated to vest on December 28, 2017.

Documents

1 file
  • 4
    formfour.xmlPrimary

    FORM 4